Drug Approved for Advanced Kidney Cancer
by on Wednesday, February 8th, 2012 | No Comments
The Food and Drug Administration (FDA) recently approved axitinib (Inlyta) to treat patients with advanced kidney cancer (renal cell carcinoma) whose disease has not responded to one course of treatment with another drug.
Read this article: Drug Approved for Advanced Kidney Cancer